pembrolizumab,Carboplatin,Docetaxel,Pegfilgrastim
merck
['tnbc', 'pembro']
 neopact trial: this single arm phase ii trial demonstrated an interesting activity of a "non-anthracycline regimen" including immunotherapy (pembrolizumab) in neoadjuvant setting for tnbc, regardless of pd-l1 and nodal status. #asco22 #bcareporter 